Amlodipine Besylate
Product Images NDC 33261-826

6 FDA label images from Aidarex Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 33261-826). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

8352ab43-figure-01 (Amlodipine Besylate For Invagen 1)

8352ab43-figure-01 (Amlodipine Besylate For Invagen 1)
Chemical structure of Amlodipine Besylate, illustrating the molecular arrangement with labeled atomic groups and bonds, including chlorine, methyl, and amino groups.*
FDA Label Image

8352ab43-figure-02 (Amlodipine Besylate For Invagen 2)

8352ab43-figure-02 (Amlodipine Besylate For Invagen 2)
A line graph showing the event rate over time in months comparing Amlodipine and Placebo groups. The x-axis represents time in months up to 24, and the y-axis shows the event rate from 0 to 0.25. The graph includes a hazard ratio of 0.691 with a 95% confidence interval of 0.54 to 0.88 and a P-value of 0.003, indicating statistical data for the comparison.*
FDA Label Image

8352ab43-figure-03 (Amlodipine Besylate For Invagen 3)

8352ab43-figure-03 (Amlodipine Besylate For Invagen 3)
A forest plot illustrating hazard ratios with 95% confidence intervals for various patient subgroups comparing Amlodipine versus placebo. Subgroups include age (<65, >=65), gender, baseline sitting systolic blood pressure (<= mean, > mean), baseline vessel disease (single, multiple), baseline vessels with stenosis (at least one vessel with >60% stenosis, no vessel with >60% stenosis), and PCI-stent strata (no PCI, PCI without stent placement, stent placement). The x-axis shows hazard ratio values ranging from 0.0 to 2.0, with a vertical reference line at 1.0.*
FDA Label Image

Image Label (Amlodipine Besylate For Invagen 4)

Image Label (Amlodipine Besylate For Invagen 4)
Amlodipine Besylate 2.5 mg tablet label from Aidarex Pharmaceuticals LLC, showing a package of 30 tablets. The label includes active ingredient information (Amlodipine Besylate 2.5 mg) and states it is generic for Norvasc. Manufactured by Invagen Pharmaceuticals, Inc., Hauppauge, NY.*
FDA Label Image

Image Label (Amlodipine Besylate For Invagen 5)

Image Label (Amlodipine Besylate For Invagen 5)
Amlodipine Besylate 5 mg 90 tablets label from Aidarex Pharmaceuticals LLC. The label states the active ingredient is amlodipine besylate 5 mg per tablet. It mentions the product is generic for Norvasc, includes the NDC 33261-0437-90, and indicates manufacturing by Invagen Pharmaceuticals, Hauppauge, NY. The label includes dosing blanks for hours and times a day and warnings about dispensing and storage.*
FDA Label Image

Image Label (Amlodipine Besylate For Invagen 6)

Image Label (Amlodipine Besylate For Invagen 6)
Amlodipine Besylate 10 mg tablet bottle label from Aidarex Pharmaceuticals LLC, containing 30 tablets. The label states it is a generic for Norvasc with NDC 33261-0535-30. Manufactured by Invagen Pharmaceuticals, Inc. The label includes dosage information areas in English and Spanish, along with a barcode and caution statements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.